Sequent Scientific receives CCI approval for composite scheme of amalgamation

Sequent Scientific announced that the Competition Commission of India vide its letter dated 21 January 2025 has approved the composite Scheme of amalgamation amongst Sequent Scientific, Symed Labs, Vandana Life Sciences, Appcure Labs, Vindhya Pharma (India), S.V. Labs, Vindhya Organics, Viyash Life Sciences, Geninn Life Sciences and Sequent Research and their respective shareholders and the creditors.

Powered by Capital Market - Live News